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Abstract 
Turner syndrome is an exclusively female genetic disease caused by complete or partial ab-
sence of the second X chromosome. It is classically characterized by congenital lymphedema, 
short stature, and gonadal dysgenesis. In addition, the syndrome is associated with several 
other abnormalities. One of them is gastrointestinal bleeding, which is frequently associated 
with inflammatory bowel disease, but it can also be caused by vascular lesions such as heman-
gioma, vascular ectasia, and telangiectasia. We report the case of a patient with Turner syn-
drome with an episode of gastrointestinal bleeding, outlining our pathway for the investigation 
and treatment of this condition. © 2018 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Turner syndrome is a chromosomal disorder that phenotypically affects females. It is 
characterized by complete or partial absence of the second X chromosome, associated with at 
least one clinical manifestation, such as typical facial features, webbed neck, lymphedema, 
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growth failure, ovarian failure, sensorineural hearing loss, and cardiovascular, skeletal, digital, 
and renal abnormalities [1–3]. Gastrointestinal bleeding has been described in this popula-
tion, especially in patients with inflammatory bowel disease [4, 5]. Additionally, episodes of 
gastrointestinal bleeding due to vascular malformations have been reported, although more 
rarely [6, 7]. We report the case of a patient with a previous diagnosis of Turner syndrome 
who presented with significant gastrointestinal bleeding after the introduction of anticoagu-
lant therapy and present a review of the related literature.  
Case Report 
A 22-year-old woman was admitted with gastrointestinal bleeding associated with enter-
orrhagia and melena. She had been diagnosed with Turner syndrome during childhood. Re-
cently, she had undergone cardiac surgery due to heart valve malformation (mechanical heart 
valve replacement) performed approximately 2 months earlier, when full coumarin anticoag-
ulation (sodium warfarin 5 mg/day) was introduced. She had a history of two episodes of gas-
trointestinal bleeding during childhood, with spontaneous resolution and no etiology defined 
after investigation.  
On admission, the patient was clinically stable, except for tachycardia (110 bpm) associ-
ated with severe anemia (hemoglobin 7.6 g/dL), requiring transfusion of 2 units of red blood-
packed cells. An upper gastrointestinal endoscopy was performed in the first 12 h of admis-
sion and showed no evidence of bleeding, but a colonoscopy performed 2 days later showed 
blood residues (melena) in all colonic segments and blood in the distal ileum, suggesting small 
bowel bleeding. 
An abdominal CT angiography showed three active bleeding sites in the lower left quad-
rant, possibly in the distal jejunum and proximal ileum. Selective angiography was performed 
in an attempt to embolize the bleeding sites, but active bleeding could not be identified.  
Due to the difficulty in locating the site of bleeding, the patient was referred to capsule 
endoscopy, which identified two active bleeding sites in the distal jejunum (Fig. 1). A double-
balloon enteroscopy revealed large, engorged vessels in the jejunoileal transition and an ero-
sion covered with hematin with signs of recent bleeding. Therapeutic endoscopy was not in-
dicated (Fig. 2).  
Considering the endoscopic findings of prominent vascularization in the small bowel, the 
patient underwent a diagnostic laparoscopy, which allowed the identification of aberrant vas-
cularization at the jejunoileal junction. An enterectomy with 60-cm resection of the small 
bowel loops was performed (Fig. 3). Anatomopathological analysis showed medium-sized ec-
tasic, congestive vessels in the mucosa and serosa compatible with vascular malformation.  
The patient progressed well postoperatively, with no new episodes of bleeding. She has 
been on outpatient follow-up with no gastrointestinal bleeding relapse. 
Discussion 
Turner syndrome is an exclusively female genetic disease, with an estimated incidence of 
1:2,500 to 1:3,000 female births [3]. It is classically characterized by congenital lymphedema, 
short stature, and gonadal dysgenesis [3]. In addition to these abnormalities originally de-
scribed by Turner, the syndrome is also associated with coarctation of the aorta and skeletal 
abnormalities [8]. 
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A relationship between gastrointestinal bleeding and Turner syndrome was first de-
scribed by Lisser et al. [8], and the diagnosis was made by diagnostic laparotomy at the time. 
The presence of gastrointestinal bleeding in this group of patients should be initially consid-
ered a sign of inflammatory bowel disease, as previous studies have reported this association, 
with an estimated prevalence of 270:100 000 [4, 5].  
Vascular lesions of the gastrointestinal tract, such as hemangioma, vascular ectasia, and 
telangiectasia, are less frequently associated with gastrointestinal bleeding in this population 
[9–11]. These lesions are considered macroscopic representations of an underlying abnor-
mality: ectasia of capillaries, venules, and veins [10]. Telangiectasia has an estimated preva-
lence of 7% [8]. This lesion may occur at any part of the gastrointestinal tract, being more 
common in the small bowel, especially in the serosa, which makes the diagnosis difficult [4].  
Vascular malformations usually cause intermittent episodes of lower gastrointestinal 
bleeding (melena), which tend to occur during the first 2 decades of life, with good response 
to iron replacement [6]. The frequency and severity of these episodes usually reduce with age 
[7, 11]. However, in rare cases, bleeding may be severe, leading to hemodynamic instability 
and risk of death [7].  
Investigation should begin with an upper gastrointestinal endoscopy, preferably within 
24 h, and, if lower gastrointestinal bleeding is suspected, a colonoscopy should be performed. 
Both methods are effective for investigation and treatment, but only if there are changes in 
the colon or duodenum [10, 11]. 
In the presence of visible bleeding not associated with hemodynamic instability, after an 
investigation of the upper and lower gastrointestinal tract, a capsule endoscopy should be 
performed as early as possible. This method has diagnostic accuracy of up to 67% in patients 
with visible bleeding and higher sensitivity and specificity than other techniques [12, 13]. A 
double-balloon or push enteroscopy should be performed guided by a previous endoscopic 
capsule, which increases the diagnostic power and enables the use of therapeutic endoscopy 
[12, 14, 15]. Thus, due to advances in the methods of investigation of the small bowel, diag-
nostic laparoscopy has been used with restrictions, being reserved for the treatment of lesions 
that cannot be approached endoscopically.  
Radiological examination is used in the following cases: (1) patients with evident bleed-
ing, when capsule endoscopy is contraindicated (intestinal obstruction or abdominal surgery 
complications) or (2) in the presence of bleeding associated with hemodynamic instability 
[12]. Abdominal CT angiography or red blood cell scintigraphy are the methods of choice and, 
if an active bleeding site is identified, they can be complemented by an abdominal angiography 
enabling a therapeutic approach through embolization [14]. Barium enema and ultrasound 
show low diagnostic accuracy and have rarely been used in this type of investigation [10, 11]. 
Treatment of these abnormalities may include drugs, endoscopy, and surgery. Drug ther-
apy is based on estrogen supplementation (associated or not with progesterone), due to 
greater microcirculatory stasis, in addition to a trophic effect on the mucosa and endothelial 
stabilization. It has shown benefits in the treatment of telangiectasias in the small bowel [16, 
17]. However, drug therapy should be used only as adjuvant therapy, as there are few ran-
domized trials and guidelines on its use [18]. Therapeutic endoscopy is effective when vascu-
lar lesions are within the reach of the endoscope, although the lesions are often multiple or 
not treatable [19]. Surgery is restricted to patients with active and refractory bleeding when 
therapeutic endoscopy and drug therapy are not feasible [6]. 
In the present case, we followed the latest guidelines for investigation of small bowel 
bleeding, which have also been used in recent reports of gastrointestinal bleeding related to 
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Turner syndrome [20, 21]. Our diagnostic approach was successful, with good outcome after 
surgery and resection of the examined segments. 
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